EMA’s human medicines committee qualifies first AI tool to diagnose inflammatory liver disease in biopsy samples: Amsterdam, The Netherlands Saturday, March 22, 2025, 16:00 Hrs ...

Nicola Heart believed that holding her newborn babies as they died would be the most difficult experience of her life. That ...

In patients with metabolic dysfunction-associated steatotic liver disease, there is increased risk for heart failure with preserved ejection fraction.

Machine learning may help identify biomarkers and develop predictive models that could assist in the diagnosis of metabolic ...

Bile duct inflammation and scarring, known as cholangiopathies, can disrupt bile flow, leading to liver damage and ...

Understanding liver fibrosis progression through machine learning provides valuable insights into disease mechanisms, ...

The use of non-invasive multiparametric MR images (LiverMultiScan) is a cost-effective tool that achieved an Incremental Cost-Effectiveness Ratio (ICER) per Quality-Adjusted Life Year (QALY) gained of ...

FibroScan overestimated advanced fibrosis and cirrhosis in patients with class 3 obesity and metabolic dysfunction-associated steatotic liver disease.

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the ...

Medically reviewed by Jay N. Yepuri, MD FibroScan is the brand name for transient elastography, an abdominal ultrasound that ...

AI-powered models can analyze large datasets in real-time, optimizing organ distribution across wider geographic regions.